L-methyl-mc Nac Coupons & Savings Card – Discount Prices from $36.54

L-Methyl-MC-NAC is a medical food designed for individuals under a physician's care for early memory loss and related conditions. It should always be used under medical supervision.

Individuals with known hypersensitivity to any components of L-Methyl-MC-NAC should not use this product. Rare reports of allergic-like reactions have been associated with its use.

Folic acid, when taken alone in doses above 0.1 mg daily, may mask the detection of vitamin B12 deficiency by correcting certain blood abnormalities without addressing neurological issues. While L-methylfolate is less likely to obscure B12 deficiency, folate therapy alone is inadequate for treating a B12 deficiency. The 2 mg of methylcobalamin in L-Methyl-MC-NAC is intended to address this concern.

N-Acetylcysteine (NAC), a component of L-Methyl-MC-NAC, should be avoided by nursing mothers. Its clearance is reduced in individuals with chronic liver disease and in pre-term newborns. Those with a history of peptic ulcer disease should use caution, as NAC may disrupt the gastric mucosal barrier. Additionally, individuals prone to forming renal stones, particularly cysteine stones, should avoid this product.

Patients with asthma or a history of bronchospasm should use NAC cautiously, as it may increase the risk of bronchospasm.

L-Methyl-MC-NAC is not recommended for use in children under the age of twelve.

Always consult with a healthcare provider before starting L-Methyl-MC-NAC to ensure it is appropriate for your specific health needs.

When considering the use of L-Methylfolate, Methylcobalamin, and N-acetylcysteine (NAC), it's important to be aware of potential interactions with other medications:

• Antiepileptic Drugs (AEDs): Medications such as Phenytoin, Carbamazepine, Primidone, Valproic Acid, fosphenytoin, valproate, Phenobarbital, and Lamotrigine may impair folate absorption and increase the metabolism of circulating folate. Additionally, concurrent use of Folic Acid has been associated with enhanced phenytoin metabolism, potentially lowering the level of the AED in the blood and allowing breakthrough seizures to occur. Caution should be used when prescribing L-methylfolate among patients who are receiving treatment with phenytoin and other anticonvulsants.

• Levodopa: Pyridoxal 5'-phosphate should not be given to patients receiving the drug levodopa, because the action of levodopa is antagonized by pyridoxal 5'-phosphate. However, pyridoxal 5'-phosphate may be used concurrently in patients receiving a preparation containing both Carbidopa and levodopa.

• Cholestyramine and Colestipol: These medications may decrease the enterohepatic re-absorption of methylcobalamin.

• Metformin, Para-aminosalicylic Acid, and Potassium Chloride: These substances may decrease the absorption of methylcobalamin.

• Nitrous Oxide: Exposure can produce a functional methylcobalamin deficiency.

• Sulfasalazine: May decrease the serum concentration of methylfolate. (medilib.ir)

• Pyrimethamine: Methylfolate may diminish the therapeutic effect of pyrimethamine. (medilib.ir)

• Raltitrexed: Methylfolate may diminish the therapeutic effect of raltitrexed; therefore, this combination should be avoided. (medilib.ir)

• Valproate Products: Methylfolate may decrease the serum concentration of valproate products. (medilib.ir)

• Chloramphenicol (Systemic): May diminish the therapeutic effect of vitamin B12. (medilib.ir)

• Charcoal, Activated: May decrease the serum concentration of acetylcysteine. (medilib.ir)

It's also important to note that NAC should be avoided by nursing mothers. Additionally, individuals with a history of peptic ulcer disease should use NAC with caution, as it may disrupt the gastric mucosal barrier. (fda.report)

Given these potential interactions, it's crucial to inform your healthcare provider about all medications and supplements you are currently taking. This will help ensure the safe and effective use of L-methylfolate, methylcobalamin, and NAC in your treatment plan.